What is it about?
Effective treatment and better patient outcomes depend on an accurate and timely diagnosis for CNS-related disorders. Biosensors, which combine biological elements with detectors, are valuable for diagnosing and treating central nervous system disorders. Biosensors, which provide sensitive, rapid, and efficient detection of disease-specific biomarkers, have become potent instruments in the diagnosis and treatment of CNS disorders. Biosensors successfully monitor disease progression, predict seizures, and track inflammatory markers.
Featured Image
Photo by Steve A Johnson on Unsplash
Why is it important?
The advancements, such as wearable biosensors, multiplexed detection, nanotechnology enhancements, and different tools for therapeutics or drug delivery systems, are paving the way for more effective and personalized CNS disorder management. The impact of nano-based materials in preparation and the requirement of biosensors in specific disorders to help in an early diagnosis and an effective approach towards treatments are highlighted.
Read the Original
This page is a summary of: Biosensors for the Diagnosis and Therapeutics of CNS-related Disorders, August 2026, Bentham Science Publishers,
DOI: 10.2174/9798898816001126010011.
You can read the full text:
Contributors
The following have contributed to this page







